Skip to main content

Advertisement

SpringerLink
Log in

Thymic factor-induced reduction of pulmonary metastases in mice with FSA-1 fibrosarcoma

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The biological activities of two thymic factors, serum thymic factor thymulin normally present in serum and thymosin alpha-1 (Ta-1) extracted from the thymus gland, have been studied. The effects of the factors on the growth of pulmonary metastases and survival of mice were evaluated in pathogen-free C3H/fSed males. Mice were injected i.v. with the single cell suspension of the syngeneic methylcholanthrene-induced fibrosarcoma.The treatment with thymulin and Ta-1 started two days after injection of 5 × 104 to 2 × 105 tumor cells per mouse. Different doses of the thymic factors were administered S.C. in sets of 5 daily injections through a period of 2 or 3 weeks. Numbers of tumor colonies in the lung were determined two weeks after the cell injection. Treatment with 0·1μg Ta-1 per injection through the period of two or three weeks, prolonged the survival of tumor-injected mice. Similar effects were observed in mice treated with 0·01μg and 0·1μg thymulin per injection. Numbers of tumor colonies in lungs of these mice two weeks after the cell injection were also reduced in comparison with saline-treated controls. These findings correlated with prolonged survival time of identically treated mice. The effectiveness of thymic factors in reducing tumor growth was dependent on the tumour load. In addition, the effects induced by Ta-1 persisted longer than observed in thymulin-treated mice. Mice challenged 150 days after the primary tumor cell injection and treatment with Ta-1 demonstrated increased resistance to tumor, while mice treated with other factors behaved as saline-treated controls.

The results indicate that both factors exert beneficial effects against tumor growth, although mode of action for each factor may be different.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allison, A. C., andTayler, R. B., 1967, Observations on thymectomy and carcinogenesis.Cancer Research,27, 703–709.

    Google Scholar 

  2. Bach, J. F., 1983, The thymus in immunodeficiency diseases; new therapy approaches.Birth Defects,19, 245–253.

    Google Scholar 

  3. Bach, J. F., 1983, Thymulin (FTS-Zn).Clinics in Immunology and Allergy,3, 133–156.

    Google Scholar 

  4. Baldwin, R. W., Byers, V. S., andRobins, R. A., 1979, Circulating immune complexes in cancer: characterization and potential as tumor markers.Behring Institute Mittelungen,64, 63–77.

    Google Scholar 

  5. Bardos, P., andBach, J. F., 1982, Modulation of mouse natural killer cell activity by the serum thymic factor (FTS).Scandinavian Journal of Immunology,15, 321–325.

    Google Scholar 

  6. Bernengo, M. G., Fra, P., Lisa, F., Meregalli, M., andZina, G., 1983, Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course.Clinical Immunology and Immunopathology,28, 311–324.

    Google Scholar 

  7. Bordioni, P., Bene, M. C., Bach, J. F., Faure, G., Dardenne, M., Duheille, J., andOlive, D., 1982, Improvement of cellular immunity and IgA production in immunodeficient children after treatment with synthetic serum thymic factor (FTS).Lancet,2, 293–297.

    Google Scholar 

  8. Carnaud, C., Hoch, B., andTrainin, N., 1974, Influence of immunologic competence of the host on metastases induced by the 3LL Lewis tumor in mice.Journal of the National Cancer Institute,52, 395–399.

    Google Scholar 

  9. Chirigos, M. A., 1978,In vitro andin vivo studies with thymosin. Immune modulation and control of neoplasia by adjuvant therapy.Progress in Cancer Research and Therapy, edited by M. A. Chirigos (New York: Raven Press), Vol. 7, p. 305.

    Google Scholar 

  10. Cupissol, D., Touraine, J. L., andSerrou, B., 1981, Ability of lymphocytes treated with thymic factor to decrease lung metastasis in tumor-bearing mice.Thymus,3, 9–16.

    Google Scholar 

  11. Doria, G., andFrasca, D., 1984, Effect of thymosin and alpha-1 on immuno-regulatory T lymphocytes.Thymic Hormones and Lymphokines: Basic Chemistry and Clinical Applications, edited by A. L. Goldstein (New York: Plenum Press), pp. 445–453.

    Google Scholar 

  12. Fidler, I. J., andHart, I. R., 1982, Biological diversity in metastatic neoplasma: origins and implications.Science,217, 361–363.

    Google Scholar 

  13. Gabizon, A., andTrainin, N., 1981, Effect of a thymic hormone, THF, on tumorbearing mice and tumor-resected mice.Cancer Immunology and Immunotherapy,10, 105–110.

    Google Scholar 

  14. Hellstrom, K. E., andHellstrom, I., 1979, Enhancement of tumor outgrowth by tumor-associated blocking factors.International Journal of Cancer,23, 366–373.

    Google Scholar 

  15. Herberman, R. B., 1983,Basic and Clinical Tumor Immunology (The Hague: Martinus Nijhoff).

    Google Scholar 

  16. Ishitsuka, H.,Umeda, Y.,Tezuka, E.,Ohta, Y., andYagi, Y., 1984, Efficacy of thymosin alpa-1 in animal models.Thymic Hormones and Lymphokines; Basic Chemistry and Clinical Applications, edited by A. L. Goldstein, pp. 425–438.

  17. Jurin, M., andSuit, H. D., 1972,In vivo andin vitro studies of the influence of the immune status of C3Hf/Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.Cancer Research,32, 2201–2211.

    Google Scholar 

  18. Jurin, M., andSuit, H. D., 1974,In vitro activity of lymphocytes and serum of C3Hf/Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.Cancer Research,34, 672–678.

    Google Scholar 

  19. Kalland, T., 1986, Effects of the immunomodulator LS2616 on growth and metastasis of the murine B16-F10 melanoma.Cancer Research,46, 3018–3022.

    Google Scholar 

  20. Klein, A. S., andShoham, J., 1981, Effect of the thymus factor, thymostimulin (TP-1), on the survival rate of tumor-bearing mice.Cancer Research,41, 3217–3223.

    Google Scholar 

  21. Lau, C. Y., Wang, E. Y., andGoldstein, G., 1982, Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice.Cellular Immunology,66, 217–232.

    Google Scholar 

  22. Ohta, Y., Sueki, K., Yoneyama, Y., Tezuka, E., andYagi, Y., 1983, Immunomodulating activity of thymosin fraction 5 and thymosin alpha 1 in immunosuppressed mice.Cancer Immunology and Immunotherapy,15, 108–113.

    Google Scholar 

  23. Savino, W., Dardenne, M., andBach, J. F., 1983, Thymic hormone-containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells.Clinical and Experimental Immunology,52, 7–12.

    Google Scholar 

  24. Shoham, J., Theoder, E., Brenner, H. J., Goldman, B., Lusky, A., andChaitchick, S., 1980, Enhancement of the immune system of chemotherapy-treated cancer patients by simultaneous treatment with thymic extract, TP-1.Cancer Immunology and Immunotherapy,9, 173–180.

    Google Scholar 

  25. Schulof, R. S., Lloyd, M. J., Ueno, W. M., Green, L. D., andStallings, J. J., 1985, A randomized trial to evaluate the immun-restorative properties of synthetic thymosin alpha 1 in patients with lung cancer.Journal of Biological Response Modifiers,4, 147–158.

    Google Scholar 

  26. Talmadge, J. E., Benedict, K. L., Uithoven, K. A., andLentz, B. F., 1984, The effects of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five).Immunopharmacology,7, 17–26.

    Google Scholar 

  27. Talmadge, J. E., Myers, K. M., Prieur, D. J., andStarkey, J. R., 1980, Role of NK cells in tumor growth and metastasis in beige mice.Nature,284, 622.

    Google Scholar 

  28. Tomazic, V. J., Novotny, E. A., andOrdonez, J. V., 1985, Thymosin alpha-1 modulation of cellular responses and functional T-cell subsets in mice with experimental autoimmune thyroiditis.Cellular Immunology,93, 340–349.

    Google Scholar 

  29. Umeda, Y., Sakamoto, A., Nakamura, J., Ishitsuka, H., andYagi, Y., 1983, Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.Cancer Immunology and Immunotherapy,15, 78–83.

    Google Scholar 

  30. Yagi, M., Yamashita, Y., andTsubura, E., 1985, Effect of a thymic factor thymostimulin, on growth and pulmonary metastases of Lewis lung carcinoma.Cancer Immunology and Immunotherapy,19, 198–204.

    Google Scholar 

  31. Zatz, M. M., Low, T. L. K., andGoldstein, A. L., 1985, Role of thymosin and other thymic hormones in T-cell differentiation.Biological Responses in Cancer, edited by E. Mihich (New York: Plenum Press), Vol. 1, pp. 219–247.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Maryland Hospital, 21201, Baltimore, Maryland, USA

    V. J. Tomazic, C. R. Sacasa, A. Loftus, C. S. Suter & G. E. Elias

Authors
  1. V. J. Tomazic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. R. Sacasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Loftus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. S. Suter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. E. Elias
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomazic, V.J., Sacasa, C.R., Loftus, A. et al. Thymic factor-induced reduction of pulmonary metastases in mice with FSA-1 fibrosarcoma. Clin Exp Metast 6, 17–25 (1988). https://doi.org/10.1007/BF01580403

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01580403

Keywords

Search

Navigation